Shane Cloney-Clark

2.6k total citations
12 papers, 111 citations indexed

About

Shane Cloney-Clark is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Shane Cloney-Clark has authored 12 papers receiving a total of 111 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 4 papers in Epidemiology and 2 papers in Molecular Biology. Recurrent topics in Shane Cloney-Clark's work include SARS-CoV-2 and COVID-19 Research (11 papers), COVID-19 Clinical Research Studies (4 papers) and Influenza Virus Research Studies (3 papers). Shane Cloney-Clark is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (11 papers), COVID-19 Clinical Research Studies (4 papers) and Influenza Virus Research Studies (3 papers). Shane Cloney-Clark collaborates with scholars based in Australia and United States. Shane Cloney-Clark's co-authors include Joyce S. Plested, Mingzhu Zhu, Louis Fries, Gregory M. Glenn, Raj Kalkeri, Alessandro Sette, Carolyn Rydyznski Moderbacher, Christina Kim, José Mateus and Shane Crotty and has published in prestigious journals such as Journal of Clinical Investigation, Clinical Infectious Diseases and Vaccine.

In The Last Decade

Shane Cloney-Clark

10 papers receiving 94 citations

Peers

Shane Cloney-Clark

IMMUN

EPIDE

ASZ

Martin Mayora Neto United Kingdom

Jessica Miller United States

Sebastian Einhauser Germany

Nicole P. Hachmann United States

Yuezhou Chen United States

Preshetha Kanagaiah United States

Cas LeMaster United States

Emily Degli-Angeli United States

Marjan Kuijer Netherlands

Camille R. Mazurek United States

Martin Mayora Neto United Kingdom

Shane Cloney-Clark

155 ×1.9

29 ×0.9

IMMUN

28 ×1.3

EPIDE

21 ×1.1

28 ×1.5

ASZ

Citations per year, relative to Shane Cloney-Clark Shane Cloney-Clark (= 1×) peers Martin Mayora Neto

Countries citing papers authored by Shane Cloney-Clark

Since Specialization

Citations

This map shows the geographic impact of Shane Cloney-Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shane Cloney-Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shane Cloney-Clark more than expected).

Fields of papers citing papers by Shane Cloney-Clark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shane Cloney-Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shane Cloney-Clark. The network helps show where Shane Cloney-Clark may publish in the future.

Co-authorship network of co-authors of Shane Cloney-Clark

This figure shows the co-authorship network connecting the top 25 collaborators of Shane Cloney-Clark. A scholar is included among the top collaborators of Shane Cloney-Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shane Cloney-Clark. Shane Cloney-Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Plested, Joyce S., Raj Kalkeri, MingZhu Zhu, et al.. (2025). Safety and immunogenicity of a single dose of a JN.1 variant COVID-19 vaccine in previously vaccinated adults: Primary analysis report of a phase 3 open-label trial. Vaccine. 73. 128164–128164.

Cai, Zhaohui, Raj Kalkeri, Mingzhu Zhu, et al.. (2024). A Pseudovirus-Based Neutralization Assay for SARS-CoV-2 Variants: A Rapid, Cost-Effective, BSL-2–Based High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation. Microorganisms. 12(3). 501–501. 6 indexed citations

Fries, Louis, Hadi Beyhaghi, Mingzhu Zhu, et al.. (2024). Mechanisms and implications of IgG4 responses to SARS-CoV-2 and other repeatedly administered vaccines. Journal of Infection. 89(6). 106317–106317. 6 indexed citations

Cai, Zhaohui, Raj Kalkeri, Mi Wang, et al.. (2024). Validation of a Pseudovirus Neutralization Assay for Severe Acute Respiratory Syndrome Coronavirus 2: A High-Throughput Method for the Evaluation of Vaccine Immunogenicity. Microorganisms. 12(6). 1201–1201. 5 indexed citations

Vincent, Timothy S., Mingzhu Zhu, Anand Parekh, et al.. (2024). A Modified Novel Validated High-Throughput Hemagglutinin Inhibition Assay Using Recombinant Virus-like Particles and Human Red Blood Cells for the Objective Evaluation of Recombinant Hemagglutinin Nanoparticle Seasonal Influenza Vaccine. Microorganisms. 12(11). 2358–2358.

Zhu, Mingzhu, Shane Cloney-Clark, Anand Parekh, et al.. (2023). A Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Immunoglobulin G Assay: A Robust Method for Evaluation of Vaccine Immunogenicity Using an Established Correlate of Protection. Microorganisms. 11(7). 1789–1789. 11 indexed citations

Davis, Matthew, Jeffrey Adelglass, Gordon Chau, et al.. (2023). Immunogenicity and safety of NVX-CoV2373 as a booster: A phase 3 randomized clinical trial in adults. Vaccine. 41(41). 5965–5973. 5 indexed citations

Plested, Joyce S., Gordon Chau, Shane Cloney-Clark, et al.. (2023). Immunogenicity and safety of a fourth homologous dose of NVX-CoV2373. Vaccine. 41(29). 4280–4286. 12 indexed citations

Plested, Joyce S., Mingzhu Zhu, Shane Cloney-Clark, et al.. (2023). Severe Acute Respiratory Syndrome Coronavirus 2 Receptor (Human Angiotensin-Converting Enzyme 2) Binding Inhibition Assay: A Rapid, High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation. Microorganisms. 11(2). 368–368. 6 indexed citations

10.

Shinde, Vivek, Wayne Woo, Sharon Liu, et al.. (2022). 2142. Safety and immunogenicity of COVID Influenza Combination Vaccine. Open Forum Infectious Diseases. 9(Supplement_2). 3 indexed citations

11.

Moderbacher, Carolyn Rydyznski, Christina Kim, José Mateus, et al.. (2022). NVX-CoV2373 vaccination induces functional SARS-CoV-2–specific CD4+ and CD8+ T cell responses. Journal of Clinical Investigation. 132(19). 37 indexed citations

12.

Shinde, Vivek, Rongman Cai, Joyce S. Plested, et al.. (2020). Induction of Cross-Reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-Cell Responses by a Recombinant Matrix-M–Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine. Clinical Infectious Diseases. 73(11). e4278–e4287. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact